View More Recent Stories
-
BioGene Therapeutics to Participate in the 43rd JP Morgan Healthcare Conference
-
PreveCeutical Announces Change of Auditors
-
BioGene Therapeutics Appoints Patroski J. Lawson to Board of Directors
-
BioGene Therapeutics Welcomes Ex Pfizer and Moderna Senior Leadership Dr. Barry Ticho
-
BioGene Therapeutics Announces Appointment of Dr. Brian Gallagher, Jr. to Corporate Advisory Board
-
BioGene Therapeutics Welcomes Stephen Glover to Its Board of Directors
-
BioGene Therapeutics Welcomes Dr. Deepak Sampath, PhD. to Its Board of Directors
-
BioGene Therapeutics Welcomes Professor Mirela Delibegovic, FRSE to Its Scientific Advisory Board
-
PreveCeutical's Subsidary, Biogene Therapeutics Announces Strategic Appointments: Dr. Linnea Olofsson as Chief Scientific Officer and Dr. Harry Parekh as Chief Research Officer
-
PreveCeutical Announces Closing of BioGene Therapeutics Transaction
-
PreveCeutical's Subsidiary, BioGene Therapeutics, Appoints President
-
PreveCeutical Launches Strategic Partnership with BioGene Therapeutics
-
PreveCeutical Engages Phoenix Corporate Finance Inc. to Provide Advisory Services
-
PreveCeutical Engages Outside The Box Capital Inc. to Provide Marketing Services
-
Preveceutical Announces Revocation of Management Cease Trade Order
-
PreveCeutical Provides Update on Management Cease Trade Order
-
PreveCeutical Enters into Loan Agreements
-
PreveCeutical Provides Update on Management Cease Trade Order
